Psychedelic 5-Methoxy-N,N-dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

Схожие документы

• Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice
  по: Shen, Hong-Wu, et al.
  Опубликовано: (2011)
• Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-Methoxy-N,N-dimethyltryptamine Metabolism and Pharmacokinetics
  по: Shen, Hong-Wu, et al.
  Опубликовано: (2010)
• Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study
  по: Shen, Hong-Wu, et al.
  Опубликовано: (2009)
• Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status
  по: Jiang, Xi-Ling, et al.
  Опубликовано: (2013)
• Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms
  по: Jiang, Xi-Ling, et al.
  Опубликовано: (2016)